234 related articles for article (PubMed ID: 17143028)
1. Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma.
Lim JS; Kim MJ; Yun MJ; Oh YT; Kim JH; Hwang HS; Park MS; Cha SW; Lee JD; Noh SH; Yoo HS; Kim KW
Korean J Radiol; 2006; 7(4):249-56. PubMed ID: 17143028
[TBL] [Abstract][Full Text] [Related]
2. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
[TBL] [Abstract][Full Text] [Related]
3. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
4. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal carcinomatosis: role of (18)F-FDG PET.
Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM
J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184
[TBL] [Abstract][Full Text] [Related]
6. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT.
Kim HW; Won KS; Zeon SK; Ahn BC; Gayed IW
Clin Nucl Med; 2013 Feb; 38(2):93-7. PubMed ID: 23334121
[TBL] [Abstract][Full Text] [Related]
14. Imaging peritoneal metastasis of gastric cancer with
Honma Y; Terauchi T; Tateishi U; Kano D; Nagashima K; Shoji H; Iwasa S; Takashima A; Kato K; Hamaguchi T; Boku N; Shimada Y; Yamada Y
Br J Radiol; 2018 Sep; 91(1089):20180259. PubMed ID: 29916721
[TBL] [Abstract][Full Text] [Related]
15. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
16. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of (18)F-FDG PET-CT and abdomen enhancement CT in diagnosing peritoneal metastases].
Wang XY; Rao LJ; Chen ZF; Shi XC; Zhang XS; Yi C
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):702-5. PubMed ID: 22851074
[TBL] [Abstract][Full Text] [Related]
19. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
[TBL] [Abstract][Full Text] [Related]
20. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
